EVALUATING THE EFFICACY OF RILUZOLE ADD-ON THERAPY ON TREATMENT SYMPTOMS OF PATIENTS WITH CONTINUOUS SCHIZOPHRENIA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

POORMAHMOOD HOSSEIN; KHODAIE ARDAKANI MOHAMMAD REZA; FADAIE FARID; ASHTARI ZABIHOLLAH; MADDAHIFARD ROGAYE; BEHJATI HODA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Studies in Medical Sciences Year:2014 | Volume:25 | Issue:10 Page(s): 862-873

Download Full-Text

Persian Verion

View:

917

Download:

Cites:

Information Journal Paper

Title

EVALUATING THE EFFICACY OF RILUZOLE ADD-ON THERAPY ON TREATMENT SYMPTOMS OF PATIENTS WITH CONTINUOUS SCHIZOPHRENIA

Author(s)

Keywords

GLUTAMATEQ3

RILUZOLEQ2

NEGATIVE SYMPTOMSQ2

SCHIZOPHRENIAQ3

Abstract

Background & Aims: This study was aimed to evaluate the efficacy of RILUZOLE (a GLUTAMATE release inhibitor) add-on therapy in the treatment of NEGATIVE SYMPTOMS of patients with chronic SCHIZOPHRENIA.Materials & Methods: This randomized, double-blind, and placebo-controlled study was conducted on thirty patients with continues SCHIZOPHRENIA (DSM-IV-TR) that were randomized considering either RILUZOLE (100 mg daily) or placebo in addition to risperidone 6 mg/day for eight weeks. The patients were assessed using positive and negative syndrome scale (PANSS) and extrapyramidal symptom rating scale (ESRS) at baseline, week 4 and 8. Hamilton depression rating scale (HDRS) was used to assess depression at baseline and week 8.Results: Thirty patients completed the trial. RILUZOLE group showed a significantly greater improvement on negative subscale than the placebo group at endpoint (P<0.001). The same effect was observed for the total score (P<0.001) and general psychopathology score (P=0.001). However the placebo and RILUZOLE groups did not differ in their reduction of positive symptoms scores. HDRS and ESRS scores and their changes did not differ between the two groups. Frequency of other side effects was similar between the two groups.Conclusions: RILUZOLE add-on can reduce the primary NEGATIVE SYMPTOMS of patients with SCHIZOPHRENIA.

Cites

No record.

References

No record.

Cite

APA: Copy

POORMAHMOOD, HOSSEIN, KHODAIE ARDAKANI, MOHAMMAD REZA, FADAIE, FARID, ASHTARI, ZABIHOLLAH, MADDAHIFARD, ROGAYE, & BEHJATI, HODA. (2014). EVALUATING THE EFFICACY OF RILUZOLE ADD-ON THERAPY ON TREATMENT SYMPTOMS OF PATIENTS WITH CONTINUOUS SCHIZOPHRENIA. STUDIES IN MEDICAL SCIENCE (THE JOURNAL OF URMIA UNIVERSITY OF MEDICAL SCINCES), 25(10), 862-873. SID. https://sid.ir/paper/64150/en

Vancouver: Copy

POORMAHMOOD HOSSEIN, KHODAIE ARDAKANI MOHAMMAD REZA, FADAIE FARID, ASHTARI ZABIHOLLAH, MADDAHIFARD ROGAYE, BEHJATI HODA. EVALUATING THE EFFICACY OF RILUZOLE ADD-ON THERAPY ON TREATMENT SYMPTOMS OF PATIENTS WITH CONTINUOUS SCHIZOPHRENIA. STUDIES IN MEDICAL SCIENCE (THE JOURNAL OF URMIA UNIVERSITY OF MEDICAL SCINCES)[Internet]. 2014;25(10):862-873. Available from: https://sid.ir/paper/64150/en

IEEE: Copy

HOSSEIN POORMAHMOOD, MOHAMMAD REZA KHODAIE ARDAKANI, FARID FADAIE, ZABIHOLLAH ASHTARI, ROGAYE MADDAHIFARD, and HODA BEHJATI, “EVALUATING THE EFFICACY OF RILUZOLE ADD-ON THERAPY ON TREATMENT SYMPTOMS OF PATIENTS WITH CONTINUOUS SCHIZOPHRENIA,” STUDIES IN MEDICAL SCIENCE (THE JOURNAL OF URMIA UNIVERSITY OF MEDICAL SCINCES), vol. 25, no. 10, pp. 862–873, 2014, [Online]. Available: https://sid.ir/paper/64150/en

Related Journal Papers